A multi-kinase inhibitor, in particular Sorafenib, is used for the preparation of a pharmaceutical composition in the treatment of a variety o pathological conditions involving vascular hyperpermeability in order to reduce vascular hyperpermeability.
USE OF MULTI-KINASE INHIBITORS IN THE TREATMENT OF VASCULAR HYPERPERMEABILITY
Carlo Stella C.
2009-01-01
Abstract
A multi-kinase inhibitor, in particular Sorafenib, is used for the preparation of a pharmaceutical composition in the treatment of a variety o pathological conditions involving vascular hyperpermeability in order to reduce vascular hyperpermeability.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
